WHO ICTRP trial
To investigate the effect of ripasudil hydrochloride hydrate eye drops for…
JPRN-UMIN000031064 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000031064 |
|---|---|
| Public title | To investigate the effect of ripasudil hydrochloride hydrate eye drops for retinal vein occlusion(RVO) |
| Scientific title | To investigate the effect of ripasudil hydrochloride hydrate eye drops for retinal vein occlusion(RVO) - The effect of ripasudil eye drops for RVO |
| Primary sponsor | Kansai Medical University Medical Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Retinal vein occlusion |
| Interventions | Administration of ripasudil eye drops twice a day for 12 months. |
| Registration date | Jan 2, 2018 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: